Maurizio Vecchione is the co-founder and co-General partner of AdAstral. He is moved by a vision that access to effective and quality healthcare is a human right and critical to equity and progress around the world.

He is jointly also serving as the president and CEO of Washington Global Health
Alliance, a non-profit organization that plays a pivotal role in fostering collaboration among leading global health institutions. He also serves as the Chief Innovation Officer of the Terasaki Institute for Biomedical Innovation, (TIBI), a non-profit research organization conducting leading-edge research in biomedicine. 

Maurizio has spent the last 30 years at the forefront of biomedicine in global and public health, focusing on innovation to improve the lives of the world’s most vulnerable people. From 2014 until 2020, he was the executive vice president for Global Good and Research at Intellectual Ventures (IV) where he oversaw collaboration with Bill Gates to invent and deploy technology to address some of humanity’s most daunting challenges. He simultaneously managed the Global Good Fund, the research programs of the Intellectual Ventures Laboratory and the Institute for Disease Modeling.

 

Maurizio has built global alliances for breakthrough programs in women’s health, infectious disease prevention and elimination, primary care, and chronic disease management as well as cancer. He has been a pioneer of the use of Artificial Intelligence in medical applications, including being involved in breakthroughs in cervical cancer screening through machine learning as well as automatic interpretation of ultrasound images via AI. He serves on the Leadership Board of the University of Washington Department of Global Health and the Advisory Board of the UCLA Ronald Reagan Medical Center; he is on the governing board of the Italian Scientists and Scholars in North America Foundation; on the Advisory Board of the Performance Theater; the editorial Board of IEEE Spectrum; an Advisor to Bill Gate’s private office Gates Ventures; an executive partner in Ethos Capital. He also has been from time to time an advisor to the US Government, the EU and multilateral organizations such as WHO and UNICEF in matters of innovation and population health.

Throughout his career, Maurizio has blended scientific research and innovation with impact investing delivering a double bottom lines of investor return and social impact.

As a serial entrepreneur & technology investor for more than two decades, Alex has deep domain expertise in enterprise software, artificial intelligence, and a wide range of emerging technologies. He spent the earlier part of his career working in strategic product management and business development roles at two of the earliest Unicorn tech startups that spawned from MIT, followed by a role working for one of the top executives at a Fortune 500 company, serving in the Office of the CTO. Subsequently, as an investor-operator, Alex has acquired & operated several technology-based businesses as CEO or Executive Chairman. 

 

Alex has had a commitment to social impact, throughout his career, via both his investing activities, and leadership across many philanthropic projects.  His venture capital investments in cellphone technologies were among the earliest to target Financial Inclusion in the developing world.  And his philanthropic work with Boston-based Social Venture Partners, in its inaugural year, led to a unique partnership between Boston-area executives and a major Food & Environment nonprofit.

 

Alex is an active member of the New York Angels, a regular mentor to more than a dozen startup incubators in NYC, and is frequently a speaker & panelist at a range of industry events.  

He has served on the Advisory Board at the Nantucket Conference, the founding board of the World Frontiers Forum, and is a longtime active participant in the TED Conference community.​  Alex has an MBA from Columbia Business School and studied finance in Mumbai, Buenos Aires, London and New York.